Cargando…

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment

Detalles Bibliográficos
Autores principales:	Ribeiro, J., Sousa, B., Cardoso, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041408/ https://www.ncbi.nlm.nih.gov/pubmed/26217109 http://dx.doi.org/10.1016/j.ejcsup.2013.07.029

Ejemplares similares

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer()
por: Harbeck, Nadia
Publicado: (2022)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
por: Kerr, Amanda J., et al.
Publicado: (2022)

Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy
por: Ng, Gary, et al.
Publicado: (2022)

Neoadjuvant radiotherapy in the approach of locally advanced breast cancer
por: Sousa, Cláudia, et al.
Publicado: (2020)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
por: Crook, Christiana J., et al.
Publicado: (2023)

Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data
por: Engel, Jutta, et al.
Publicado: (2022)

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
por: Artzy-Randrup, Yael, et al.
Publicado: (2021)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Palbociclib in breast cancer neoadjuvant setting
por: Duarte, Sílvia Alexandra Cabral, et al.
Publicado: (2021)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011)

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
por: Advani, Pooja, et al.
Publicado: (2015)

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
por: Tian, Hao, et al.
Publicado: (2021)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning()
por: Rubio, Isabel T., et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

The optimal approach to early breast cancer
por: Wyld, Lynda
Publicado: (2013)

The PROMISe to increase precision in adjuvant therapy for early breast cancer: To “Type” or to “Print”?
por: Cardoso, Fatima, et al.
Publicado: (2018)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Neoadjuvant treatment: the future of patients with breast cancer
por: Reyal, F, et al.
Publicado: (2018)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
por: Basho, Reva K., et al.
Publicado: (2018)

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
por: Ribi, K, et al.
Publicado: (2012)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer
por: Kunst, Natalia, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Trastuzumab in the Adjuvant Treatment for Early Breast Cancer
por: Aboutorabi, Ali, et al.
Publicado: (2015)

The Effect of Neoadjuvant vs Adjuvant Chemotherapy on Final Outcome of Patients with Triple Negative Breast Cancer
por: Dabbagh, Najmeh, et al.
Publicado: (2022)

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
por: Suppan, Christoph, et al.
Publicado: (2021)

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
por: Huo, Xingfa, et al.
Publicado: (2021)

Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis
por: Klein, Jonathan, et al.
Publicado: (2019)

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_5c2vo2ia2k7640lk3gjdjdtf0g